Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3022% above fair value
$349.38−0.50 (-0.14%)
Close on Nov 12, 2026Market cap $66.67BP/E 25.9Yield 0.63%
Cencora total assets
Total assets on the balance sheet at the end of each period.
Cencora's total assets was $83.81B at Jun 30, 2026. For fiscal 2025 it was $76.59B, up 14.1% from the year before. Over ten years it grew 10.6% a year on average. The highest annual figure on record is $76.59B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $76.59B | +14.1% |
| FY2024 | Sep 30, 2024 | $67.10B | +7.3% |
| FY2023 | Sep 30, 2023 | $62.56B | +10.6% |
| FY2022 | Sep 30, 2022 | $56.56B | -1.4% |
| FY2021 | Sep 30, 2021 | $57.34B | +29.5% |
| FY2020 | Sep 30, 2020 | $44.27B | +13.0% |
| FY2019 | Sep 30, 2019 | $39.17B | +4.0% |
| FY2018 | Sep 30, 2018 | $37.67B | +6.7% |
| FY2017 | Sep 30, 2017 | $35.32B | +5.0% |
| FY2016 | Sep 30, 2016 | $33.64B | +20.3% |
| FY2015 | Sep 30, 2015 | $27.96B | +29.9% |
| FY2014 | Sep 30, 2014 | $21.53B | +13.8% |
| FY2013 | Sep 30, 2013 | $18.92B | +22.5% |
| FY2012 | Sep 30, 2012 | $15.44B | +3.1% |
| FY2011 | Sep 30, 2011 | $14.98B | +3.8% |
| FY2010 | Sep 30, 2010 | $14.43B | +6.4% |
| FY2009 | Sep 30, 2009 | $13.57B | +11.1% |
| FY2008 | Sep 30, 2008 | $12.22B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $83.81B | +13.3% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $81.65B | +14.7% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $78.36B | +13.5% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $76.59B | +14.1% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $73.96B | +10.8% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $71.19B | +11.5% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $69.05B | +6.7% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $67.10B | +7.3% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $66.77B | +9.1% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $63.87B | +8.7% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $64.69B | +11.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $62.56B | +10.6% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $61.18B | +7.0% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $58.77B | +2.5% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $57.91B | +0.6% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $56.56B | -1.4% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $57.17B | +2.2% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $57.31B | +21.9% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $57.58B | +25.6% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $57.34B | +29.5% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $55.93B | +37.1% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $47.00B | +11.8% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $45.85B | +14.6% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $44.27B | +13.0% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $40.79B | +6.0% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $42.04B | +8.3% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $40.02B | +1.9% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $39.17B | +4.0% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $38.48B | +0.4% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $38.81B | +1.1% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $39.27B | +8.0% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $37.67B | +6.7% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $38.31B | +10.5% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $38.40B | +11.6% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $36.36B | +7.2% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $35.32B | +5.0% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $34.65B | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $34.40B | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $33.92B | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $33.64B | – |
See a number that looks wrong?